AK

Abdul Kadir Waris Ansari

Active Director Director DIN 09613050
DIN 09613050 First appointment May 2022 Primary industry Home Appliances
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Abdul Kadir Waris Ansari

Data last updated:

Abdul Kadir Waris Ansari is a Director at Sw Pharmaceuticals Private Limited (since 2022). The company operates in Home Appliances.

DIN 09613050
Primary Designation Director
Industry Home Appliances
First Appointment 20 May 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sw Pharmaceuticals Private Limited U52100MH2022PTC383024
Director20 May 20222022Active

Board colleagues of Abdul Kadir Waris Ansari

NameDINCompanyDesignation
Mohammed Vasid Ansari09613049Sw Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sw Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Abdul Kadir Waris Ansari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdul Kadir Waris Ansari

Abdul Kadir Waris Ansari currently holds 1 directorship: Sw Pharmaceuticals Private Limited (Director, since 20 May 2022).

Abdul Kadir Waris Ansari was first appointed on 20 May 2022 as Director at Sw Pharmaceuticals Private Limited.

The current boards of Abdul Kadir Waris Ansari's companies include Mohammed Vasid Ansari (Sw Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available